Novavax Inc (NAS:NVAX)
$ 12.93 -0.27 (-2.05%) Market Cap: 2.07 Bil Enterprise Value: 1.30 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 65/100

Q3 2022 Novavax Inc Earnings Call Transcript

Nov 08, 2022 / 09:30PM GMT
Release Date Price: $19.65 (+1.13%)
Operator

Good afternoon, and welcome to the Novavax Third Quarter 2022 Financial Results and Operational Highlights. (Operator Instructions) Please note that this event is being recorded. I would now like to turn the conference over to Silvia Taylor, Executive Vice President, Chief Communications Officer. Please go ahead.

Silvia Taylor
Novavax, Inc. - SVP of Global Corporate Affairs & IR

Good afternoon, and thank you all for joining us today to discuss our third quarter 2022 operational highlights and financial results. A press release announcing our results is currently available on our website at novavax.com, and an audio archive of this conference call will be available on our website later today.

Before we begin with prepared remarks, I need to remind you that this presentation includes forward-looking statements, including information relating to the future of Novavax, its key strategic priorities, plans and prospects for 2022 and financial guidance, including total revenue; the ongoing development of our vaccine candidates, including anticipated

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot